These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus. Perandini LA, Sales-de-Oliveira D, Mello S, Camara NO, Benatti FB, Lima FR, Borba E, Bonfa E, Roschel H, Sá-Pinto AL, Gualano B. Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870 [Abstract] [Full Text] [Related]
3. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects. Arora V, Verma J, Marwah V, Kumar A, Anand D, Das N. Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832 [Abstract] [Full Text] [Related]
4. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M. Anticancer Res; 2001 May; 21(4B):3053-9. PubMed ID: 11712810 [Abstract] [Full Text] [Related]
5. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus. Sabry AA, Elbasyouni SR, Kalil AM, Abdel-Rahim M, Mohsen T, Sleem A. Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573 [Abstract] [Full Text] [Related]
6. [Proinflammatory cytokines in inactive lupus erythematosus patients]. Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Lukamowicz J, Robak E, Wozniacka A. Przegl Lek; 2005 Aug; 62(9):838-42. PubMed ID: 16541713 [Abstract] [Full Text] [Related]
7. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA, El-Gendi HI, Ahmed HH. Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275 [Abstract] [Full Text] [Related]
8. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity. Robak E, Sysa-Jedrzejewska A, Dziankowska B, Torzecka D, Chojnowski K, Robak T. Arch Immunol Ther Exp (Warsz); 1998 Feb; 46(6):375-80. PubMed ID: 9883317 [Abstract] [Full Text] [Related]
9. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. López P, Gómez J, Prado C, Gutiérrez C, Suárez A. J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405 [Abstract] [Full Text] [Related]
10. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response. Lacki JK, Leszczynski P, Kelemen J, Müller W, Mackiewicz SH. J Med; 1997 Aug; 28(1-2):99-107. PubMed ID: 9249616 [Abstract] [Full Text] [Related]
11. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients. Umare V, Pradhan V, Nadkar M, Rajadhyaksha A, Patwardhan M, Ghosh KK, Nadkarni AH. Mediators Inflamm; 2014 Aug; 2014():385297. PubMed ID: 25548434 [Abstract] [Full Text] [Related]
12. Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus. Cigni A, Pileri PV, Faedda R, Gallo P, Sini A, Satta AE, Marras R, Carta E, Argiolas D, Rum I, Masala A. J Investig Med; 2014 Jun; 62(5):825-9. PubMed ID: 24987977 [Abstract] [Full Text] [Related]
13. Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis. Sabry A, Elbasyouni SR, Sheashaa HA, Alhusseini AA, Mahmoud K, George SK, Kaleek EA, abo-Zena H, Kalil AM, Mohsen T, Rahim MA, El-samanody AZ. Int Urol Nephrol; 2006 Jun; 38(3-4):731-7. PubMed ID: 17260180 [Abstract] [Full Text] [Related]
14. Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets. Yamamoto N, Yamaguchi H, Ohmura K, Yokoyama T, Yoshifuji H, Yukawa N, Kawabata D, Fujii T, Morita S, Nagata S, Mimori T. Lupus; 2014 Apr; 23(4):386-94. PubMed ID: 24554711 [Abstract] [Full Text] [Related]
15. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. Li J, Xie H, Wen T, Liu H, Zhu W, Chen X. J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525 [Abstract] [Full Text] [Related]
16. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA. J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987 [Abstract] [Full Text] [Related]
17. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. McCarthy EM, Smith S, Lee RZ, Cunnane G, Doran MF, Donnelly S, Howard D, O'Connell P, Kearns G, Ní Gabhann J, Jefferies CA. Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988 [Abstract] [Full Text] [Related]
18. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus. Postal M, Peliçari KO, Sinicato NA, Marini R, Costallat LT, Appenzeller S. Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615 [Abstract] [Full Text] [Related]
19. [Abnormality and significance of interleukin-9 and CD4(+)interleukin-9(+) T-cells in peripheral blood of patients with systemic lupus erythematosus]. Ouyang H, Shi YB, Su N, Li LY. Zhonghua Yi Xue Za Zhi; 2013 Jan 08; 93(2):99-103. PubMed ID: 23648344 [Abstract] [Full Text] [Related]
20. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus. Rana A, Minz RW, Aggarwal R, Anand S, Pasricha N, Singh S. Lupus; 2012 Sep 08; 21(10):1105-12. PubMed ID: 22759859 [Abstract] [Full Text] [Related] Page: [Next] [New Search]